Blackstone Inc
BIOTW

Blackstone Inc’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Blackstone Inc’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-250,000
Closed -$165K – 423
2021
Q4 		$165K Hold
250,000
– – ﹤0.01% 408
2021
Q3 		$165K Hold
250,000
– – ﹤0.01% 474
2021
Q2 		$215K Hold
250,000
– – ﹤0.01% 480
2021
Q1 		$150K Buy
+250,000
New +$176K ﹤0.01% 433

Other funds holding BIOTW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Blackstone Inc's BIOTW Position: Q1 2022 in Review

Blackstone Inc sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2022, closing a stake of 250,000 shares — an estimated $165K sold.

Blackstone Inc first reported a position in BIOTW in Q1 2021 and held it in 4 quarters. The position peaked at $215K in Q2 2021. 52 funds tracked by Wall St. Rank hold BIOTW as of Q1 2022.

  • Blackstone Inc reported no remaining Biotech Acquisition Company Warrant position as of Q1 2022 after selling out during the quarter.
  • Blackstone Inc sold 250,000 Biotech Acquisition Company Warrant shares in Q1 2022, an estimated $165K.
  • Blackstone Inc first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 4 quarters.
  • Blackstone Inc's Biotech Acquisition Company Warrant position peaked at $215K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2022.

Based on Blackstone Inc's 13F filing for Q1 2022, filed 16 May 2022.